Income Statement
Balance Sheet
Cash Flow
| Line Item | Q2 2025May 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 | Q3 2024Aug 31, 2024 | Q2 2024May 31, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 185,381 | 330,535 | 299,500 | 429,090 | 449,469 |
| General And Administrative Expense | 87,552 | 248,010 | 177,617 | 179,594 | 270,705 |
| Other Operating Expenses | 239,752 | 209,878 | 309,055 | 70,479 | 369,815 |
| Operating Expense | 425,133 | 540,413 | 608,555 | 499,569 | 819,284 |
| Operating Income | -425,133 | -540,413 | -608,555 | -499,569 | -819,284 |
| EBIT | -425,133 | -540,413 | -608,555 | -499,569 | -819,284 |
| Interest Income | 47.00 | 2,711 | 8,030 | 30,451 | 20,350 |
| Interest Income Non Operating | 47.00 | 2,711 | 8,030 | 30,451 | 20,350 |
| Net Interest Income | 47.00 | 2,711 | 8,030 | 30,451 | 20,350 |
| Other Income Expense | -385,320 | 630,151 | 398,512 | 594,756 | 752,914 |
| Other Non Operating Income Expenses | -5,534 | 581,954 | 562,620 | 265,979 | 838,736 |
| Special Income Charges | -- | -- | 0.00 | 0.00 | 0.00 |
| Gain On Sale Of Security | -379,786 | 48,197 | -164,108 | 328,777 | -85,822 |
| Pretax Income | -810,406 | 92,449 | -202,013 | 125,638 | -46,020 |
| Tax Effect Of Unusual Items | 0.00 | 7,230 | 0.00 | 49,317 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -810,406 | 92,449 | -202,013 | 125,638 | -46,020 |
| Net Income From Continuing Operation Net Minority Interest | -810,406 | 92,449 | -202,013 | 125,638 | -46,020 |
| Net Income Including Noncontrolling Interests | -810,406 | 92,449 | -202,013 | 125,638 | -46,020 |
| Net Income Common Stockholders | -810,406 | 92,449 | -202,013 | 125,638 | -46,020 |
| Net Income | -810,406 | 92,449 | -202,013 | 125,638 | -46,020 |
| EBITDA | -425,133 | -540,413 | -608,555 | -499,569 | -819,284 |
| Normalized EBITDA | -45,347 | -588,610 | -444,447 | -828,346 | -733,462 |
| Basic EPS | -0.01 | 0.00 | -- | 0.00 | 0.00 |
| Diluted EPS | -0.01 | 0.00 | -- | 0.00 | 0.00 |
| Basic Average Shares | 154.2M | 150.7M | -- | 148.2M | 147.6M |
| Diluted Average Shares | 154.2M | 150.7M | -- | 148.2M | 147.6M |
| Total Unusual Items | -379,786 | 48,197 | -164,108 | 328,777 | -85,822 |
| Total Unusual Items Excluding Goodwill | -379,786 | 48,197 | -164,108 | 328,777 | -85,822 |
| Tax Rate For Calcs | 0.00 | 0.15 | 0.00 | 0.15 | 0.00 |
| Normalized Income | -430,620 | 51,482 | -37,905 | -153,822 | 39,802 |
| Diluted NI Availto Com Stockholders | -810,406 | 92,449 | -202,013 | 125,638 | -46,020 |
| Impairment Of Capital Assets | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Income Continuous Operations | -810,406 | 92,449 | -202,013 | 125,638 | -46,020 |
| Net Non Operating Interest Income Expense | 47.00 | 2,711 | 8,030 | 30,451 | 20,350 |
| Other Gand A | 86,836 | 244,759 | 153,594 | 154,614 | 257,159 |
| Salaries And Wages | 716.00 | 3,251 | 24,023 | 24,980 | 13,546 |
| Selling And Marketing Expense | 97,829 | 82,525 | 121,883 | 249,496 | 178,764 |
| Total Expenses | 425,133 | 540,413 | 608,555 | 499,569 | 819,284 |
| Line Item | Q2 2025May 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 | Q3 2024Aug 31, 2024 | Q2 2024May 31, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 742,728 | 1.5M | 2.1M | 3.0M | 4.1M |
| Cash Cash Equivalents And Short Term Investments | 849,178 | 1.9M | 2.6M | 3.6M | 4.4M |
| Cash Financial | 742,728 | -- | -- | -- | -- |
| Other Short Term Investments | 106,450 | 482,187 | 429,934 | 587,975 | 261,014 |
| Accounts Receivable | -- | -- | 147,077 | 294,855 | 261,106 |
| Receivables | 176,490 | 262,112 | 147,077 | 294,855 | 261,106 |
| Prepaid Assets | 128,490 | 118,517 | 209,954 | 286,333 | 525,275 |
| Current Assets | 1.2M | 2.3M | 2.9M | 4.1M | 5.1M |
| Net PPE | 11.2M | 10.7M | 9.2M | 7.9M | 7.3M |
| Total Non Current Assets | 11.4M | 10.8M | 9.4M | 8.1M | 7.5M |
| Total Assets | 12.5M | 13.2M | 12.4M | 12.2M | 12.6M |
| Accounts Payable | 887,176 | 838,321 | 965,397 | 278,848 | 443,485 |
| Payables | 896,384 | 864,046 | 986,560 | 314,405 | 519,834 |
| Payables And Accrued Expenses | 1.6M | 1.6M | 1.9M | 950,583 | 1.2M |
| Current Accrued Expenses | 739,517 | 729,205 | 874,200 | 636,178 | 684,749 |
| Other Current Liabilities | -- | -- | 587,488 | 1.3M | 1.6M |
| Current Liabilities | 1.6M | 1.6M | 2.4M | 2.3M | 2.8M |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 1.6M | 1.6M | 2.4M | 2.3M | 2.8M |
| Common Stock | 49.3M | 48.7M | 46.7M | 46.4M | 46.4M |
| Capital Stock | 49.3M | 48.7M | 46.7M | 46.4M | 46.4M |
| Retained Earnings | -40.2M | -39.3M | -39.4M | -39.2M | -39.3M |
| Gains Losses Not Affecting Retained Earnings | 1.7M | 2.0M | 2.6M | 2.7M | 2.7M |
| Common Stock Equity | 10.9M | 11.6M | 9.9M | 9.9M | 9.8M |
| Stockholders Equity | 10.9M | 11.6M | 9.9M | 9.9M | 9.8M |
| Total Equity Gross Minority Interest | 10.9M | 11.6M | 9.9M | 9.9M | 9.8M |
| Total Capitalization | 10.9M | 11.6M | 9.9M | 9.9M | 9.8M |
| Net Tangible Assets | 10.9M | 11.6M | 9.9M | 9.9M | 9.8M |
| Tangible Book Value | 10.9M | 11.6M | 9.9M | 9.9M | 9.8M |
| Working Capital | -481,743 | 736,896 | 479,287 | 1.9M | 2.3M |
| Invested Capital | 10.9M | 11.6M | 9.9M | 9.9M | 9.8M |
| Share Issued | 154.4M | 153.2M | 148.7M | 148.2M | 148.2M |
| Ordinary Shares Number | 154.4M | 153.2M | 148.7M | 148.2M | 148.2M |
| Dueto Related Parties Current | 9,208 | 25,725 | 21,163 | 35,557 | 76,349 |
| Non Current Prepaid Assets | 156,314 | 148,408 | 229,433 | 200,895 | 150,145 |
| Other Equity Interest | -- | 144,775 | -- | -- | -- |
| Other Receivables | 176,490 | 262,112 | -- | -- | -- |
| Line Item | Q2 2025May 31, 2025 | Q1 2025Feb 28, 2025 | Q4 2024Nov 30, 2024 | Q3 2024Aug 31, 2024 | Q2 2024May 31, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -424,236 | -655,127 | -344,047 | -269,384 | -1.2M |
| Cash Flow From Continuing Operating Activities | -424,236 | -655,127 | -344,047 | -269,384 | -1.2M |
| Stock Based Compensation | 716.00 | 3,251 | 24,023 | 24,980 | 13,546 |
| Change In Working Capital | 131.00 | -120,676 | 407,594 | 174,754 | -455,750 |
| Change In Receivables | 84,892 | -114,305 | 147,778 | -33,749 | -153,272 |
| Change In Payables And Accrued Expense | -75,518 | -97,078 | 183,437 | -30,439 | 23,216 |
| Other Non Cash Items | 105,584 | -581,954 | -737,759 | -265,979 | -838,736 |
| Capital Expenditure | -- | -1.7M | -634,999 | -824,746 | -1.5M |
| Purchase Of PPE | -- | -1.7M | -634,999 | 1.7M | -1.5M |
| Net PPE Purchase And Sale | -2.2M | 81,025 | -634,999 | 1.7M | -1.5M |
| Investing Cash Flow | -527,367 | -1.6M | -641,726 | -844,601 | -1.2M |
| Cash Flow From Continuing Investing Activities | -527,367 | -1.6M | -634,999 | -844,601 | -1.2M |
| Issuance Of Capital Stock | -- | 144,775 | 0.00 | 0.00 | 0.00 |
| Net Common Stock Issuance | -- | 144,775 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 227,000 | 1.6M | 141,750 | 0.00 | 328,990 |
| Cash Flow From Continuing Financing Activities | 227,000 | 1.6M | 141,750 | 0.00 | 328,990 |
| Changes In Cash | -724,603 | -673,239 | -837,296 | -1.1M | -2.1M |
| Beginning Cash Position | 1.5M | 2.1M | 3.0M | 4.1M | 6.2M |
| End Cash Position | 742,728 | 1.5M | 2.1M | 3.0M | 4.1M |
| Free Cash Flow | -2.6M | -655,127 | -979,046 | 1.4M | -2.7M |
| Asset Impairment Charge | -- | -- | 0.00 | 0.00 | 0.00 |
| Change In Prepaid Assets | -9,243 | 90,707 | 76,379 | 238,942 | -325,694 |
| Common Stock Issuance | -- | 144,775 | 0.00 | 0.00 | 0.00 |
| Net Foreign Currency Exchange Gain Loss | 4,049 | 4,056 | 6,067 | -1,816 | 8,428 |
| Net Income From Continuing Operations | -910,453 | 92,449 | -202,013 | 125,638 | -46,020 |
| Net Intangibles Purchase And Sale | -- | -- | 0.00 | 0.00 | -- |
| Net Other Financing Charges | -- | 144,775 | -- | -- | -- |
| Net Other Investing Changes | -- | -1.7M | -613,188 | -793,851 | -1.5M |
| Operating Gains Losses | 4,049 | 4,056 | 7,479 | -1,816 | 8,428 |
| Proceeds From Stock Option Exercised | 371,775 | 1.4M | 141,750 | 200,000 | 128,990 |
| Sale Of Intangibles | -- | -- | 0.00 | 0.00 | -- |
| Sale Of PPE | -7,906 | 81,025 | 0.00 | -19,855 | -- |
| Unrealized Gain Loss On Investment Securities | 375,737 | -52,253 | -- | -326,961 | 77,394 |